Immuneering (IMRX) Q2 2026 Earnings

15MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.53
-0.42
-0.32
-0.21

Details

Expected EPS
-0.252
Actual EPS
-0.21
Surprise EPS
0.04
Surprise Percent
+16.67%

Description

Immuneering (IMRX) has reported earnings of -0.21 per share for Q2 2026.

0 Comments

Share your thoughts